Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SHEESH! Looks like 9 billion! Wow! Well it's not the worst out there, but it's certainly not the best. Only good thing about that, is that if it does run, it'll be very slow & steady. But it's really just a watcher for me so far. I'd have to see a couple hundred million go thru before I'd even make a move for my mouse.
I'm thinking she'll run. I'll be watching the .0002s carefully. I know the .0001s got eaten yesterday by those who I guess were "in the know". It'll be interesting. The OTC/Pink market doesn't play out as it used to a couple of years ago. Half the time I don't know how the market will react now... =P So basically it's just something to "watch" right now IMO...
LBTN (.0002) Authorizes Stock Exchange Program to Shareholders
Business Wire "US Press Releases "
RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced the Company is offering a share exchange program to its common stock shareholders. Lifeline Biotechnologies, Inc. will offer to exchange its Series B Convertible Preferred Stock, to be valued by the Company at $1.00 per share, for common shares of stock held by its shareholders as of the record date, which the Company is valuing at $.001 per share, a premium to the current market price. This means for every 1,000 shares of common stock submitted to the Company for exchange, shareholders will receive one share of Series B Convertible Preferred Stock valued at $1.00 for future conversion purposes.
Current shareholders must have their shares into OTC Corporate Transfer Service Company by May 4, 2007, unless extended by the Company, in order to qualify for the exchange of common shares to Series B Convertible Preferred Shares. In order to qualify for the exchange, shareholders must submit a minimum of 100,000 shares of common stock. The Series B Convertible Preferred Stock will be protected from any future stock restructuring by the Company. For the complete terms and conditions of the stock exchange program, the Company will be posting particulars on its website www.lbtn.com. In addition, the Company will prepare and mail to its shareholders of record an Information Statement disclosing the terms and conditions of the exchange.
"We are very pleased to be able to offer our shareholders this exchange program. With the program announcement today, we are reaffirming our confidence and optimism in the long-term future of the Company. As more information becomes available, it will be provided on our website and/or through press releases," stated Jim Holmes, President of Lifeline Biotechnologies, Inc.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of disease conditions. The Company's technologies, designed to assist in the early detection of cancers, deal with cutting-edge innovation to assist practicing physicians in the delivery of quality medical care. The First Warning System(TM), a process for assisting in the early detection of breast cancer, is continuing to be developed by the Company. More information is available at the company's website: www.lbti.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Exchange Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, the ability to obtain financing and regulatory and shareholder approval for anticipated actions.
To automatically receive instant updates, press releases and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
Source: Lifeline Biotechnologies, Inc.
LBTN (.0002) Authorizes Stock Exchange Program to Shareholders
Business Wire "US Press Releases "
RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced the Company is offering a share exchange program to its common stock shareholders. Lifeline Biotechnologies, Inc. will offer to exchange its Series B Convertible Preferred Stock, to be valued by the Company at $1.00 per share, for common shares of stock held by its shareholders as of the record date, which the Company is valuing at $.001 per share, a premium to the current market price. This means for every 1,000 shares of common stock submitted to the Company for exchange, shareholders will receive one share of Series B Convertible Preferred Stock valued at $1.00 for future conversion purposes.
Current shareholders must have their shares into OTC Corporate Transfer Service Company by May 4, 2007, unless extended by the Company, in order to qualify for the exchange of common shares to Series B Convertible Preferred Shares. In order to qualify for the exchange, shareholders must submit a minimum of 100,000 shares of common stock. The Series B Convertible Preferred Stock will be protected from any future stock restructuring by the Company. For the complete terms and conditions of the stock exchange program, the Company will be posting particulars on its website www.lbtn.com. In addition, the Company will prepare and mail to its shareholders of record an Information Statement disclosing the terms and conditions of the exchange.
"We are very pleased to be able to offer our shareholders this exchange program. With the program announcement today, we are reaffirming our confidence and optimism in the long-term future of the Company. As more information becomes available, it will be provided on our website and/or through press releases," stated Jim Holmes, President of Lifeline Biotechnologies, Inc.
About Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies, Inc. is a company with innovative medical technologies committed to the improvement of the quality of life through exceptional health care systems. These technologies focus on prevention, early detection, diagnosis and quick recovery of disease conditions. The Company's technologies, designed to assist in the early detection of cancers, deal with cutting-edge innovation to assist practicing physicians in the delivery of quality medical care. The First Warning System(TM), a process for assisting in the early detection of breast cancer, is continuing to be developed by the Company. More information is available at the company's website: www.lbti.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Exchange Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties, including, without limitation, the ability to obtain financing and regulatory and shareholder approval for anticipated actions.
To automatically receive instant updates, press releases and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.
Source: Lifeline Biotechnologies, Inc.
I completely see your side of it and agree. 8 mill is nothing in the overall scheme of things. Just not getting the volume today to handle that type of selling (if you were to dump today). That's all I was saying...
hmmm... i appreciate the disclaimer, but it does worry me...
Thanks Lobster... me thinks the 5s will crack...
=) .0006s coming in now
IFQJ getting .0005 hits now
IFQJ ut
ECFR... what a creeper... .0001 ticks...
EFCR going on news
GBDX uting PM wooohoooo!!!
I'm hearing one trillion dollars/share for the buyout!!! =)
LOL
me too, sublime. Have a great evening folks. Let's hope a lot of this momentum from today continues over to tomorrow.
Signing off....
Lobster & Sublime congrats on ACUP. I see it panning out quite well for you soon.
In GBDX @ .007... looking for a .01 run possibly...
StockLobster,
you still need to put my lotto pick on the board when you get a chance.
5,000,000 RNKE @ .0001
it's getting closer...
AQUX: ameritrade online trading restriction =\
AQUX: Ameritrade online trade restriction in affect
CWIR: are there still 4 @ ASK?
CWIR: are there still 4 on ASK?
How's the L2 looking?
Thanks, Lobster... always appreciated!
EWDC: laughable shake attempt
How's the L2 stackin?
CWIR: can someone L2 it please. Volume surging...
How's the FMLY L2 stacking?
In EWDC for a 0.01 run, Good luck to all... signing off with this last msg... See you guys tomorrow! =)
I'm going to go ahead and say EWDC will be flirting with .01 this week IMO. Just a hunch....
PXIT L2 please, if anyone has time. TIA...
ABZA flying on Google news
How's the L2 looking?
How's it stacking?
PXIT getting frisky
EWDC... i'm in for the bounce off of the brutal past 5 days...
EWDC was bound to bounce after 5 just brutal days...
EWDC thar she blows!!!